Feb 22, 2019 - Readers familiar with my work know I’m a long-time fundamentals kind of guy. But unlike many in this camp, I see technical analysis as an ally, not an enemy.Now, with the market having completed the u
Feb 21, 2019 - Genomic Health's (GHDX) year-over-year rise in revenues, driven by a solid uptick in the United States and internationally, makes us optimistic about the stock.
Feb 14, 2019 - DaVita's (DVA) Q4 results gain from increasing dialysis services in and outside the United States.
Feb 13, 2019 - Top Ranked Momentum Stocks to Buy for February 13th
Feb 07, 2019 - Bright Near-Term Outlook for Medical Instruments Industry
Feb 07, 2019 - Cardinal Health's (CAH) Q2 results benefit from strong sales in the Pharmaceutical segment. An upbeat guidance is indicative of brighter prospects.
Feb 06, 2019 - Cerner (CERN) gains from solid segmental revenues in fourth-quarter 2018. However, the company's 2019 guidance disappoints.
Feb 05, 2019 - QIAGEN's (QGEN) suffers sluggish sales at Americas. However, the company delivers strong global growth.
Feb 05, 2019 - Medical Instruments companies are likely to gain from strong performance in emerging economies and modernization of 510 (k)-clearance pathway by the FDA in Q4.
Feb 04, 2019 - Omnicell (OMCL) gains from expanding into new markets. Stiff rivalry is a concern.